By Paul Sankey
Published on February 29, 2024 at 9:03 AM
Market backdrop: our argument that low US refining utilisation this month (Feb 2024) would tend to pressure crude prices, tighten product inventories, and raise product prices, is not working at all, leading us to demand concerns. Refiners have been weak accordingly, even if background GDP data and better than expected China numbers suggest a good year for refiners. It’s not all bad news: crude oil prices are acting well. Generally with seasonality, tough January weather …
Read More
By Paul Sankey
Published on February 13, 2024 at 8:47 AM
At 6x pro forma EBITDA, FANG should be worth $180-190/share considering $11-12B EBITDA, less purchase-price adjusted net debt and midstream subsidiary Venom (VNOM) non-controlling interest. From there, it is a gravitational pull to $200. Everyone loves round numbers. Like 5,500 on the S&P500. Or Nvidia $1,000. But for oils, we have to rely on fundamental cashflow-based valuation. Source: Company reports, Sankey Research ~ Today’s WSJ feature on Autrey Stephens, the owner of Endeavor Energy, confirms …
Read More
By Paul Sankey
Published on February 10, 2024 at 11:23 AM
Never Let a Good Crisis Go To Waste There was a groan went up at Sankey Research at this week’s Reuters report that Devon was in talks to acquire Enerplus Corp (ERF). Why? The news broke as we were completing this note, which argues exactly the OPPOSITE strategy for Devon, than buying a company in the Bakken. We think they should SELLL the Bakken. And more besides, and we outline that herein. We agree DVN …
Read More
